詳細検索結果
以下の条件での結果を表示する: 検索条件を変更
クエリ検索: "矢部喜正"
148件中 1-20の結果を表示しています
  • 宮坂 宗男, 西村 純一, 大工園 則雄, 藤島 一郎, 矢部 喜正, 大城 俊夫, 渥美 和彦
    日本レーザー医学会誌
    1987年 8 巻 1 号 15-26
    発行日: 1987年
    公開日: 2012/09/24
    ジャーナル フリー
  • 中野 元, 矢部 喜正
    日本レーザー医学会誌
    1997年 18 巻 4 号 41-54
    発行日: 1997年
    公開日: 2012/09/24
    ジャーナル フリー
    波長2.08μmのHo: YAGと波長2.01μmのTm: YAGを用いlaser coronary angioPlastyを行った。対象はHo: YAG18例, 全例1枝病変例でRCA5例, LAD11例, Cx2例である。術前の%DSは75.4±4.0, MLDは0.76±0.45拍田を示した。acute successは56% (10/18), 全例にadjunctive ballooningを施行しprocedural successを全例に得た。% DSの推移ではlaser alone 49.6±17.1, ballooning 24.7±12.2を示した。また, 遠隔期の再造影ではrestenosisは17% (3/18) と遠隔成績は良好であった。
    一方, Tm: YAGは対象17例, target lesionはRCA4例, LAD7例, Cx1例およびprotected LMCAを5例からなる。術前の% DSは80.0±9.4, MLDは0.68±0.35mmを示した。acute success 65% (11/17), 全例にballooningを行い, 100%のprocedural successを得た。%DSの推移はlaser alone 56,2±17.7, ballooningに26.4±12.8を示した。遠隔期の再造影の結果, 再狭窄を18% (3/17) に認めた。また, protected LMCA 5例については4例にacute successを得, 再狭窄を1例に認めた。Ho: YAG, Tm: YAG両群共にmajor complicaしionを認めず, 共に安全性に優れ, 確実な蒸散効果を有し臨床的有効性が示された。
  • 村松 俊哉, 矢部 喜正, 加藤 雅彦, 野池 博文, 吉田 哲, 中野 元, 斉藤 徹, 上嶋 権兵衛
    動脈硬化
    1990年 18 巻 2 号 209-216
    発行日: 1990/02/01
    公開日: 2011/09/21
    ジャーナル フリー
    Mechanism of restenosis after PTCA suggests that platelets play an important role in this response. Since a stable PGI2 analogue, U-61, 431F (group U), has strong platelet inhibitory action, we investigated the preventing effect of U-61, 431F on restenosis and other complications in patients undergoing PTCA. The effect was compared with control (group C). There was no difference in patients background in the two groups. No abrupt coronary occlusion or other cardiac events were observed in group U, but there was two events in group C. Though there was no significant difference in the results between the 2 groups, group U showed lower patient restenosis rate (group U: group C 33.3%:57.1%) and lesion restenosis rate (group U: group C 25.0%:37.5%) based on follow-up angiography. No serious adverse effect was observed in the group U. Thus U-61, 431F may be effective in preventing acute cardiac events during PTCA and restenosis after PTCA.
  • Nitroglycerin, TrapidilおよびNifedipineの血行動態に及ぼす影響
    坂本 貞和, 籠島 忠, 千頭 敏史, 大塚 文明, 橋本 俊雄, 中堀 克己, 薮田 又弘, 石川 兵衛
    臨床薬理
    1984年 15 巻 1 号 103-104
    発行日: 1984/03/30
    公開日: 2010/06/28
    ジャーナル フリー
  • 荒川 宏, 栗田 明, 里村 公生, 渋谷 利雄, 五十嶋 一成, 青崎 登, 細野 清士, 水野 杏一
    臨床薬理
    1983年 14 巻 1 号 53-54
    発行日: 1983/03/30
    公開日: 2010/06/28
    ジャーナル フリー
  • 岡本 淳, 矢部 喜正, 大沢 秀文, 中野 元, 野池 博文, 村松 俊哉, 相原 正彦
    動脈硬化
    1990年 18 巻 6 号 661-665
    発行日: 1990/06/01
    公開日: 2011/09/21
    ジャーナル フリー
    A high incidence of restenosis at the site of successful PTCA is a major problem with this procedure. Among the various factors, thromboxane A2 (TXA2) and PGI2 may have important roles on the restenosis in this mechanism. DP-1904 (DP), an imidazole derivative, is a potent selective TXA2 synthetase inhibitor with prolonged activity. It also increases PGI2 formation. In this study, the effect of DP on post-PTCA restenosis was compared with a placebo control taken from a recent trial conducted under an equivalent protocol. Angina and OMI patients receiving first elective PICA were enrolled in the study. Oral dosing of DP 600mg/day started at least 3 days before PTCA and continued until re-CAG at 3 months after PICA At re-CAG, restenosis was evaluated by lesion and patient based on the patency achieved at PICA. 1) Very good: no restenosis or expansion, 2) Good: <50% loss, 3) Poor: 50%≤loss<100%, 4) Very poor: 100% loss or more progressed stenosis before PICA. 19 patients (29 lesions) were evaluated in the DP group, and 15 (26 lesions) in the placebo group. DP: placebo evaluation of the stenotic lesion was: Very good 9: 5, Good 15: 10, Poor 2: 8 and Very poor 3: 3, indicating DP-s efficacy (Wilcoxon P=0.10). Evaluation by patient restenosis was: 26.3% in the DP group, 66.7% in the placebo group, showing DP's statistically significant efficacy over placebo (Wilcoxon P<0.05). No side effects were observed in the DP group. Plasma TXB2/6-keto-PGF ratio showed preferable changes during DP dosing: pre-dosing (2.58±0.82pg/ml), pre-PICA (0.60±0.13), immediately post-PICA (0.57±0.09) and 3 months post-PICA (0.84±0.09).
  • PTCAとの対比を中心として
    小松 壽, 矢部 喜正, 小山 信弥, 海老根 東雄, 高梨 吉則
    日本外科系連合学会誌
    1990年 1990 巻 22 号 8-11
    発行日: 1990/07/30
    公開日: 2009/08/13
    ジャーナル フリー
  • 超音波変位計を用いた多点計測による Stiffness parameterβ 分布について
    川崎 健, 竹内 光吉, 長谷川 元治, 八木 晋一, 岸 良典
    動脈硬化
    1980年 8 巻 2 号 383-388
    発行日: 1980/07/01
    公開日: 2011/09/21
    ジャーナル フリー
    With intension of noninvasive, quantitative analysis of arteriosclerosis of carotid artery, we design ultrasonic, phase-locked echo tracking system. (Materials and method) Materials are consisted of 169 cases from 3 to 59 years old. Measuring system is shown in Fig. (2). The measured portions are four points along the common carotid artery containing carotid sinus. Fig. (2). We use stiffness parameterβ by Hayashi as a index of elastic property of artery. We can calculate it by following equation. β=ln Pmax/Pmin·D/ΔD, where Pmax is maximum pressure, Pmin is minimum pressure, D is diastolic diameter, and ΔD is the diameter change during the heart cycle. Now we fix the probe softly on the measuring position. The electric pulses are sonified into the body of the object through transducer as 5MHZ ultrasonic pulses. Then pulses reflected from the vessel walls are monitored on A-scope screen. Two tracking gates are set to follow automatically the movement of the echoes corresponding to the wall motion. Such behavior of the wall is recorded by the pen recorder. Fig. (3). Thus giving us the diameter change (ΔD) of the vessel during the heart cycle as well as diastolic diameter (D). Blood pressure are measured on the upper arm. (Result) 1. The each diameter of common carotid artery is almost same along the portions (B, C, D, ) and that of sinus (E) is a little larger than the others. In any portions the diameters are became larger with aging. Fig. (4). 2. We calculate stiffness parameterβ at each portion on common carotid artery in each individuals. Fig. (5), Fig. (6). β is increased with aging in any portions. But under 29 years old, we can find no difference between four portions on carotid artery, and the difference between each individuals is small. Over 30 years old, β is became higher with remarkable difference between four portions. Over 40, β of carotid sinus is became higher pecuriarly than the others (B, C, D, ). We can find this tendency more clearly over 50 years old. 3. The standard deviation of β at carotid sinus over 40 is higher than that of the other portions clearly. We can recognize the appearance of material change in common carotid artery.
  • ―内科治療・外科治療(CABG)・PTCA(経皮的冠動脈拡張術)治療成績の比較と冠動脈病変進展防止について―
    矢部 喜正
    動脈硬化
    1985年 13 巻 4 号 793-807
    発行日: 1985/10/01
    公開日: 2011/09/21
    ジャーナル フリー
    The study examined the progresses of a coronary arterial disease among medical, surgical and PTCA treated groups and compared the long-term results with anti-platelet therapy (trapidil 300mg/day or persantin 75mg+aspyrin 300mg/day) or Ca2+ channel blockade (nifedipine 40mg/day) groups. 323 patients with effort angina were studied. These were grouped into Group I (96 patients treated medically), Group 11 (147 patients who underwent CABG) and Group III (84 patients treated with PTCA). Group I was further divided into 3 subgroups; I-B 37 cases who were administered with anti-platelet drug for a long period of time, I-C 21 cases who were administered with Ca2+ channel blockade and I-A 38 cases with whom none of the 2 drugs was administered. Group II was likewise divided into 3 subgroups of II-B, anti-platelet administered group, II-C, Ca2+ channel blockade administered group and II-A, non-administered group. The observation was conducted in 3 to 60 months (average 12.4 months) after the 1st CAG. Serial CAG were taken in each case. The standard of the progress diagnosis was based on Kramer's criteria. RESULTS & CONCLUSION: 1) Among I-A group patients, progress, non-progress, and regress cases were, 50, 40 and 5%, respectively. 55% of the patients showed progress had the effect within 12 months. The level of progress after this period co-relates to the length of observa-tion period, showing 72% peak in over 2 yrs. Relationship with affected vessels; Progress of the responsible coronary arterial vessel with patients involving single vessel disease showed the highest record. The highest rate was with the cases where the disease progressed to a complete occlusion (type 1). On the other hand, among B and C groups, the rate of progress after 2 yrs remarkably became low (p<0.01). LV function was favorable both with I-B, I-C groups. With II-A group, the rate of progress was high in non-grafted vessels within one to one year and a half period with high ratio of type 1, while with II-B, II-C groups, a difference in progress was observed. Among B group patients progression and regression were 33, and 13% within 12 months. While, among C groups, progression, non-progression, and regression were 35, 44 and 21%. 2) Among Group III, 9 cases or 13% showed recurrence of the initially dilated vessel. Of these, 56% showed a significant progress in initally dilated vessel; however, a good result was observed after the 2nd PTCA. 3) These drugs were considered as preventing the progression of coronary artery disease. It is concluded that for angina pectoris patients, a specific treatment program should be established to prevent the progress of the disease, in addition to a conventional therapeutical program. 4) Synergistic effects of these drugs might be resulted from vascular injury suppression, platelet inhibition, coronary vasodilation, improvement of lipids metabolism as well as improvement of LV performance.
  • 非再狭窄病変例での検討
    中野 元, 矢部 喜正, 内田 俊彦
    心臓
    1999年 31 巻 7 号 547-555
    発行日: 1999/07/15
    公開日: 2013/05/24
    ジャーナル フリー
    平均4.1カ月後の確認造影にて再狭窄を認めず,3年以上経過観察後に追跡冠動脈造影を施行し得た症例を対象としPTCA後の自然歴と長期予後について検討を加えた.PTCA施行血管での新規病変発生は2.3%であるのに対し,非施行血管では14.5%と有意(p<0.01)に高く,再狭窄を免れた病変は長期にわたり良好な開存性を有することが確認された.新規病変はacute coronary syndromeや造影上intimal disruptionを認め,粥腫崩壊や血栓形成がcardiac event発生につながる可能性もあり,十分な内科管理が重要と考えられた.
  • 村松 俊哉, 矢部 喜正
    JAPANESE CIRCULATION JOURNAL
    1993年 56 巻 SupplementV 号 1425-1432
    発行日: 1993/01/20
    公開日: 2008/04/14
    ジャーナル フリー
  • 村松 俊哉, 矢部 喜正, 中野 元, 塚原 玲子, 池田 基昭, 我妻 賢司
    心電図
    1992年 12 巻 4 号 425-435
    発行日: 1992/07/31
    公開日: 2010/09/09
    ジャーナル フリー
    ホルター心電図を用いてPTOA直後のSMIを同定し臨床的予後に及ぼす影響につき検討した.対象は初回待機的PTOA成功例直後のホルター心電図上SMIを認めなかった62例 (A群) とSMIを認めた10例 (B群) とした.ホルター心電図はPTOA前, 直後, 1週間後, 4ヵ月後の4回記録しSMI出現頻度の推移も検討した.その結果, トレッドミル運動負荷試験におけるPTOA前後の運動耐容能の推移はA群においては有意に改善するのに比し, B群のそれは改善は示すも有意ではなかった.患者再狭窄率はA群26.6%, B群50%, 病変別再狭窄率はA群20.7%, B群35.3%を示しB群はA群に比し有意に高率であった.SMI出現頻度の推移を検討すると, B群は高率であったがA群は漸次減少した.PTOA直後のSMIは残存虚血, electrical hibernationを示唆する一つの所見であり, PTOA後再狭窄に関連し得る.
  • 上松瀬 勝男
    循環器専門医
    1999年 7 巻 2 号 269
    発行日: 1999/10/15
    公開日: 2018/05/28
    ジャーナル フリー
  • 森川 則文, 樋口 和子, 塚本 豊久, 中野 節, 寺田 弘
    YAKUGAKU ZASSHI
    1989年 109 巻 11 号 858-864
    発行日: 1989/11/25
    公開日: 2008/05/30
    ジャーナル フリー
  • 矢部 喜正, 長瀬 英義, 小山 信弥, 大沢 秀文, 内 孝, 真田 竹生, 小松 壽, 亀谷 壽彦, 鈴木 慎一郎, 森下 健
    心臓
    1982年 14 巻 1 号 110-118
    発行日: 1982/01/25
    公開日: 2013/05/24
    ジャーナル フリー
    患者は40歳女性で昭和49年左心不全症状にて入院,その際血沈亢進,CRP陽性,白血球増多などの全身炎症所見を呈しsteroid投与を受け著効を示した. 昭和54年1月より労作時前胸部痛の出現を見,昭和54年6月Cine angiography施行.大動脈造影にて肥厚,拡張型gradeIII regurgitationを認め選択的冠動脈造影にて左主冠動脈に99%の入口部狭窄性病変と共に左前下行枝冠動脈近位部に血栓形成と思われる陰影欠損像を認めた. 昭和54年10月大動脈弁置換術後およびA-C bypass術施行し前胸部痛は寛解し術後のCineangiography study においても心機能の明らかな改善が得られた.また大動脈弁置換術の際採取された大動脈壁全層の組織学的検索では外膜側の線維性肥厚,豊富な栄養血管とその周周に著明な炎症細胞浸潤の病理所見を得た.大動脈炎症候群の冠動脈病変の合併は比較的まれとされるが今回著者らは本症候群に伴う大動脈弁閉鎖不全症並びに左冠状動脈入口部狭窄病変の合併例の興味ある1症例を経験した.
  • 小山 信弥, 吉原 克則, 伊藤 信行, 鵜養 恭介, 海老根 東雄, 小松 寿, 亀谷 寿彦, 矢部 喜正
    日本心臓血管外科学会雑誌
    1984年 13 巻 4 号 327-330
    発行日: 1984/03/20
    公開日: 2009/04/28
    ジャーナル フリー
  • 虚血症心疾患 その1
    望月 正武, 矢部 喜正, 小山 信弥, 大沢 秀文, 元山 幹雄, 内 孝, 佐藤 靖史, 坂井 誠, 上田 慶二, 井上 純一, 片岡 一, 大川 真一郎, 杉浦 昌也, 村上 元孝, 鈴木 孝臣, 板垣 晃之, 早川 道夫, 関 増爾, 久我 正文, 久保 雅博, 新谷 博一, 寺沢 富士夫, 篠原 文雄, 井上 紳, 長谷 川貢, 吉田 文英, 藤巻 忠夫, 関 克美, 川崎 建市, 細田 瑳一, 岡田 了三, 北村 和夫, 安田 紀久雄, 元田 憲, 多賀 邦章, 清水 賢己, 孫崎 信久, 名村 正伸, 竹田 亮祐, 南堂 公平, 竹内 英子, 門間 正幸, 岡村 哲夫, 須階 二朗
    日本老年医学会雑誌
    1981年 18 巻 18-supl 号 35-37
    発行日: 1981/09/15
    公開日: 2010/03/01
    ジャーナル フリー
  • 横山 和則, 岡田 嘉之, 乙供 通稔, 後藤 敏和, 三浦 民夫, 荒木 隆夫, 横山 紘一
    心臓
    1986年 18 巻 9 号 1123-1127
    発行日: 1986/09/15
    公開日: 2013/05/24
    ジャーナル フリー
    A-Cバイパス術後早期に,グラフト末梢吻合部狭窄に起因する血栓性グラフト閉塞をきたした症例に対し,緊急にPTCRを行いグラフトの再開通を得た後にPTCAを施行し吻合部狭窄が良好に解除された1例を経験したので報告する.
    症例は60歳の男性で,左前下行枝に90%,左回旋枝に50%の狭窄を有する不安定狭心症の診断にて,昭和59年11月1日に大伏在静脈グラフトを用い左前下行枝(seg.7)にA-Cバイパス術を行った.術後経過は良好で抗凝固療法を受けながら通院を続けていたが,約5カ月後の夜中に突然前胸部痛が出現し,約5時間後に当院緊急受診した.心電図上はantero-septal infarctionが疑われ,ただちに冠動脈造影を施行しグラフト内近位部よりの閉塞が認められた.さらに,PTCR(ウロキナーゼ72万単位)を行ったところグラフトの再開通とともに末梢吻合部の99%狭窄が確認された.そこで,3日後にPTCAを施行した.バルーンカテーテル(2.5mm拡張)をグラフト内より狭窄部まで進め,計3回の拡張により狭窄はほぼ消失した.その後の経過は良好で,心電図および心筋シンチグラム(201Tl)でも満足すべき結果であった.
    グラフト閉塞に対するPTCRおよびPTCA療法の報告はまだ少ないが,適応を充分考慮することにより有効な治療手段になると考えられた.
  • ―冠動脈造影による検討―
    矢部 喜正, 石川 眞一郎, 内 孝, 河村 康明, 浜野 昌平, 奥住 一雄, 宮入 誠, 大沢 秀文, 森下 健, 望月 正武
    動脈硬化
    1984年 12 巻 2 号 445-451
    発行日: 1984/06/01
    公開日: 2011/09/21
    ジャーナル フリー
    Comparative study on natural history of coronary atherosclerosis in 83 patients with effort angina between medical and surgical group were designed based on two coronary arteriograms.
    The second coronary arteriograms were performed averaged 9 months after the initial angiography. Progression or regression were defined as 6 categories in severity of each coronary artery based on Kramer's criteria.
    1) Incidence of progression was found in 50 of all patients with no relation to the age. Especially, the types of that were most frequently recognized as the categories of a) less than 100 to 100%, b) less than 30% to greater than 50%.While, the incidence of regression was found in only 4% with the non-infarcted patients.
    2) As for progression in relation to the interval, the peak of that's incidence was recognized as one year later after CABG, however, these incidences were significant within 6 months in both groups.
    3) In relation to coronary artery, the incidence of progression was highest in right coronary artery with medical group. On the other hand, that was significantly high in left circumflex coronary artery of the non-grafted vessels surgically.
    4) As conclusion, serial coronary arteriograms are very important to evaluate the progressive arterial change or regression in patients with the ischemic heart disease.
  • 池田 裕政, 坪田 輝彦, 浅野 健夫
    動脈硬化
    1987年 15 巻 4 号 1033-1037
    発行日: 1987/08/01
    公開日: 2011/09/21
    ジャーナル フリー
    Pulse wave velocity of aorta (PWV) was measured and chest X-ray was taken in 114 patients.
    PWV is a method of examining the degree of atherosclerosis non-invasively. The first left arch of mediastinum in the frontal image of a chest X-ray represents a part of the aorta, and it changes depending on the degree of atherosclerosis.
    PWV was studied comparatively with regard to the degrees of calcification and projection of the aortic arch, and the following conclusions were arrived at:
    (1) The aortic arch calcification group in chest
    X-ray showed a significantly higher PWV value than the non-calcification group (p<0.001).
    (2) However, as a result of the comparison of PWV between the groups of calcification and noncalcification at the same age above the 40's, no significant difference was obtained except in the 50's.
    (3) The group with prominent projection of the aortic arch towards the left shoulder joint showed a significantly higher PWV value than the group with a slight projection (p<0.05).
    From the above, it is considered justified to suspect an atherosclerotic disease in cases showing the above changes of the aortic arch and to examine them thoroughly.
feedback
Top